XML 73 R61.htm IDEA: XBRL DOCUMENT v3.22.0.1
Acquisitions - Summarized Fair Values of Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Mar. 04, 2021
Dec. 31, 2020
Oct. 23, 2020
MYR        
Intangible assets:        
Deferred income taxes, net   $ (513)    
Other assets (and liabilities), net   (187)    
Total identifiable net assets   1,335    
Goodwill   226    
Total consideration   1,561    
MYR | Acquired IPR&D        
Intangible assets:        
Acquired IPR&D   1,190    
MYR | Hepcludex        
Intangible assets:        
Finite-lived intangible asset   $ 845    
Immunomedics, Inc.        
Business Acquisition [Line Items]        
Cash and cash equivalents       $ 726
Inventories $ 294   $ 797 946
Intangible assets:        
Deferred income taxes, net       (4,565)
Liability related to future royalties       (1,100)
Other assets (and liabilities), net       64
Total identifiable net assets       16,606
Goodwill       3,991
Total consideration       20,597
Immunomedics, Inc. | Acquired IPR&D        
Intangible assets:        
Acquired IPR&D       15,760
Immunomedics, Inc. | Trodelvy        
Intangible assets:        
Finite-lived intangible asset       4,600
Immunomedics, Inc. | Outlicense contract        
Intangible assets:        
Finite-lived intangible asset       $ 175